In the Media

A CRISPR-based diagnostic tool for Covid-19 developed by researchers from MIT and other institutions has been granted emergency FDA approval, reports Joel Achenbach and Laurie McGinley for The Washington Post. “We think this has a lot of potential. The test doesn’t require any complicated or expensive equipment,” explains Prof. Feng Zhang.